Akari Therapeutics, Plc
AKTX
$1.07
-$0.04-3.60%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 09/30/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.25M | 4.18M | 1.31M | -- | 3.85M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 396.00K | 805.00K | 1.23M | -- | 299.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 92.00K | 94.00K | 232.00K | -- | 197.00K |
| Total Current Assets | 2.73M | 5.08M | 2.77M | -- | 4.34M |
|
|
|||||
| Total Current Assets | 2.73M | 5.08M | 2.77M | -- | 4.34M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | 14.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 2.73M | 5.08M | 2.77M | -- | 4.36M |
|
|
|||||
| Total Accounts Payable | 4.78M | 4.69M | 3.21M | -- | 1.67M |
| Total Accrued Expenses | 2.61M | 1.69M | 1.53M | -- | 1.57M |
| Short-term Debt | 1.00M | 1.00M | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 1.04M | 1.41M | 1.59M | -- | 1.35M |
| Total Other Current Liabilities | 1.04M | 1.41M | 1.59M | -- | 1.35M |
| Total Current Liabilities | 9.43M | 8.78M | 6.33M | -- | 4.58M |
|
|
|||||
| Total Current Liabilities | 9.43M | 8.78M | 6.33M | -- | 4.58M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 1.00M | 1.00M | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 9.43M | 8.78M | 6.33M | -- | 4.58M |
|
|
|||||
| Common Stock & APIC | 185.52M | 185.44M | 178.04M | -- | 176.08M |
| Retained Earnings | -243.48M | -240.59M | -233.03M | -- | -227.46M |
| Treasury Stock & Other | 51.27M | 51.45M | 51.43M | -- | 51.15M |
| Total Common Equity | -6.69M | -3.70M | -3.55M | -- | -229.00K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -6.69M | -3.70M | -3.55M | -- | -229.00K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -6.69M | -3.70M | -3.55M | -- | -229.00K |
|
|
|||||
